medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2015, Número 3

<< Anterior Siguiente >>

Dermatología Cosmética, Médica y Quirúrgica 2015; 13 (3)


Dermatofibrosarcoma protuberans: revisión bibliográfica

Molinari L, Luna AM, Ferrario D, Galimberti G, Galimberti R

Idioma: Español
Referencias bibliográficas: 69
Paginas: 201-213
Archivo PDF: 274.25 Kb.


RESUMEN

El dermatofibrosarcoma protuberans es el sarcoma cutáneo más frecuente. Se caracteriza porque presenta crecimiento lento, con bajo potencial metastásico pero con un alto grado de recurrencias locales, debido a su elevada capacidad de invasión local. El objetivo de este estudio es hacer una revisión de la epidemiología, características clínicas, histología, inmunohistoquímica, pronóstico y tratamiento de este raro tumor.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Llombart, B., Serra-Guillén, C., Monteagudo, C. et al., “Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management”, Semin Diagn Pathol, 2013, 30: 13-28.

  2. Chaput, B., Filleron, T., Le Guellec, S. et al., “Dermatofibrosarcoma protuberans: Margins reduction using slow-Mohs micrographic surgery. Experience with 35 patients”, Ann Chir Plast Esthet, 2014, http://dx.doi. org/10.1016/j.anplas.2013.11.001.

  3. Boguki, B., Neuhaus, I. y Hurst, E.A., “Dermatofibrosarcoma protuberans: a review of the literature”, Dermatol Surg, 2012, 38 (4): 537-551.

  4. Criscione, V.D. y Weinstock, M.A., “Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002”, J Am Acad Dermatol, 2007, junio, 56: 968-973.

  5. Marini, M.A., Parra, L.S., Cordero, A. et al., “Dermatofibrosarcoma protuberans”, en Marini, M.A., Casas, J.G. y Saponaro, A.E., Tumores cutáneos malignos infrecuentes: sarcomas, Alfaomega, Buenos Aires, 2012, 17-39.

  6. Posso-De los Ríos, C.J., Lara-Corrales, I. y Ho, N., “Dermatofibrosarcoma protuberans in pediatric patients: a report of 17 cases”, J Cutan Med Surg, 2014, 18 (3): 180-185.

  7. Tsai, Y.J., Lin, P.Y., Chew, K.Y. et al., “Dermatofibrosarcoma protuberans in children and adolescents: clinical presentation, histology, treatment and review of the literature”, J Plast Reconstr Aesthet Surg, 2014, doi: 10.1016/j.bjps.2014.05.031.

  8. Saeki, H., Ohmatsu, H., Hoashi, T. et al., “Dermatofibrosarcoma protuberans with col1a1(exon18)-pdgfb(exon 2) fusion transcript”, British Journal of Dermatology, 2003, 148: 1028-1031.

  9. Stamatakos, M., Fyllos, A., Siafogianni, A. et al., “Dermatofibrosarcoma protuberans: a rare entity and review of the literature”, jbuon, 2014, 19 (1): 34-41.

  10. Reddy, K.K., Hanke, C.W. y Tierney, E.P., “Malignancy arising within cutaneous tattoos: a case of dermatofibrosarcoma protuberans and review of the literature”, J Drugs Dermatol, 2011, 10 (8): 837-842.

  11. Martin, L., Piette, F., Blanc, P. et al., “Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans”, Br J Dermatol, 2005, 153: 932-936.

  12. Bowne, W.B., Antonescu, C.R., Leung, D.H. et al., “Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution”, Cancer, 2000, 88: 2711-2720.

  13. Fiore, M., Miceli, R. y Mussi, C., “Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate”, J Clin Oncol, 2005, 23: 7669-7675.

  14. Serra-Guillén, C., Llombart, B., Nagore, E. et al., “High immunohistochemical nestin expression is associated with greater deph of infiltration in dermatofibrosarcoma protuberans: a study of 71 cases”, J Cutan Pathol, 2013, 40 (10): 871-878.

  15. Serra-Guillén, C., Sanmartín, O., Llombart, B. et al., “Correlation between preoperative magnetic resonance imaging and surgical margins with modified Mohs for dermatofibrosarcoma protuberans”, Dermatol Surg, 2011, 37: 1638-1645.

  16. Pallure, V., Dupin, N. y Guillot, B., “Surgical treatment of Darier-Ferrand Dermatofibrosarcoma: A systematic review”, Dermatol Surg, 2013, 39: 1417-1433, doi: 10.1111/dsu.12299.

  17. Galimberti, G., Pontón Montaño, A., Kowalczuk, A. et al., “Outcomes in 11 patients with dermatofibrosarcoma protuberans trested with Mohs micrographic surgery”, Int J Dermatol, 2012, 51: 89-93.

  18. Paradisi, A., Abeni, D., Rusciani, A. et al., “Dermatofibrosarcoma protuberans: Wide local excision vs. Mohs micrographic surgery”, Cancer Treatment Reviews, 2008, 34: 728-736.

  19. Hollmig, S.T., Sachdev, R., Cockerell, C.J. et al., “Spindle cell neoplasms encountered in dermatologic surgery: a review”, Dermatol Surg, 2013, 38 (6): 825-850.

  20. Lemm, D., Mügge, L.O., Mentzel, T. et al., “Current treatment options in dermatofibrosarcoma protuberans”, J Cancer Res Clin Oncol, 2009, 135: 653-665.

  21. Kokkinos, C., Sorkin, T. y Powell, B., “To Mohs or not to Mohs”, J Plast Reconstr Aesthet Surg, 2014, 67: 23-26.

  22. Bichakjian, C.K., Olencki, T., Alam, M. et al., “Dermatofibrosarcoma protuberans”, version 1.2014, J Natl Compr Canc Netw, 2014, junio, 12 (6): 863-868.

  23. Hersant, B., May, P., Battistella, M. et al., “Reducing surgical margins in dermatofibrosarcoma protuberans using the pathological analysis technique ‘vertical modified technique’: a 5-year experience”, J Plast Reconstr Aesthet Surg, mayo, 2013, 66 (5): 617-622.

  24. Stojadinovic, A., Karpoff, H.M., Antonescu, C.R. et al., “Dermatofibrosarcoma protuberans of the head and neck”, Ann Surg Oncol, 2000, 7(9): 696-704.

  25. Joucdar, S., Kismoune, H., Boudjemia, F. et al., “Darrier and Ferrand dermatofibrosarcomas retrospective analysis of 81 cases over ten years (1983–1994)”, Ann Chir Plast Esthet, 2001, 46 (2): 134-140.

  26. D’Andrea, F., Vozza, A., Brongo, S. et al., “Dermatofibrosarcoma protuberans: experience with 14 cases”, J Eur Acad Dermatol Venereol, 2001, 15 (5): 427-429.

  27. Khatri, V.P., Galante, J.M., Bold, R.J. et al., “Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment”, Ann Surg Oncol, 2003, 10 (9): 1118-1122.

  28. Chang, C.K., Jacobs, I.A. y Salti, G.I., “Outcomes of surgery for dermatofibrosarcoma protuberans”, Eur J Surg Oncol, 2004, 30: 341-345.

  29. DuBay, D., Cimmino, V., Lowe, L. et al., “Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution”, Cancer, 2004, 100: 1008-1016.

  30. Behbahani, R., Patenotre, P., Capon, N. et al., “To a margin reduction in the dermatofibrosarcomaprotuberans? Retrospective study of 34 cases”, Ann Chir Plast Esthet, 2005, 50 (3): 179-185.

  31. Monnier, D., Vidal, C., Martin, L. et al., “Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002”, J Eur Acad Dermatol Venereol, 2006, 20: 1237-1242.

  32. Popov, P., Bohling, T., Asko-Seljavaara, S. et al., “Microscopic margins and results of surgery for dermatofibrosarcoma protuberans”, Plast Reconstr Surg, 2007, 119: 1779-1784.

  33. Chien, C.R., Chang, Y.L., Lin, D.T. et al., “Excellent survival of pediatric dermatofibrosarcoma protuberans in Taiwanese”, Pediatr Surg Int, 2007, 23 (3): 211-214.

  34. Stivala, A., Lombardo, G.A.G., Pompili, G. et al., “Dermatofibrosarcoma protuberans: Our experience of 59 cases”, Oncol Lett, 2012, 4: 1047-1055.

  35. Molinari, L., Galimberti, G., Ferrario, D. et al., “Dermatofibrosarcoma protuberans. Cirugía micrográfica de Mohs vs. cirugía convencional”, Piel, 2011, 26 (10): 532-537.

  36. Breuninger, H. y Schaumburg-Lever, G., “Control of excisional margins by conventional histopathological techniques in the treatment of skin tumours. An alternative to Mohs’ technique”, J Pathol, 1988, 154: 167-171.

  37. Tan, W.P., Barlow, R.J., Robson, A. et al., “Dermatofibrosarcoma protuberans: 35 patients treated with Mohs micrographic surgery using paraffin sections”, Br J Dermatol, 2011; 164: 363-366.

  38. Parker, T.L. y Zitelli, J.A., “Surgical margins for excision of dermatofibrosarcoma protuberans”, J Am Acad Dermatol, 1995, 32: 233-236.

  39. Dawes, K.W. y Hanke, C.W., “Dermatofibrosarcoma protuberans treated with Mohs micrographic surgery: cure rates and surgical margins”, Dermatol Surg, 1996, 22 (6): 530-534.

  40. Clayton, B.D., Leshin, B., Hitchcock, M.G. et al., “Utility of rush paraffinembedded tangential sections in the management of cutaneous neoplasms”, Dermatol Surg, 2000, 26 (7): 671-678.

  41. Snow, S.N., Gordon, E.M., Larson, P.O. et al., “Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature”, Cancer, 2004, 101 (1): 28-38.

  42. González, A., Marini, M.A., Cordero, A. et al., “La importancia de la técnica micrográfica de Mohs en el tratamiento del dermatofibrosarcoma protuberans”, Act terap Dermatol, 2008, 31: 22-29.

  43. Yu, W., Tsoukas, M.M., Chapman, S.M. et al., “Surgical treatment for dermatofibrosarcoma protuberans: the Dartmouth experience and literature review”, Ann Plast Surg, 2008, 60 (3): 288-293.

  44. Love, W.E., Keiler, S.A., Tamburro, J.E. et al., “Surgical management of congenital dermatofibrosarcoma protuberans”, J Am Acad Dermatol, 2009, 61 (6): 1014-1023.

  45. Serra-Guillén, C., Llombart, B., Nagore, E. et al., “Positive margins in excised dermatofibrosarcoma protuberans: a study of 58 cases treated with slow- Mohs surgery”, J Eur Acad Dermatol Venereol, 2013, doi: 10.1111/jdv.12235.

  46. Loghdey, S., Varma, S., Rajpara, S.M. et al., “Mohs micrographic surgery for dermatofibrosarcoma protuberans (dfsp): A single centre series of 76 patients treated by frozen section Mohs micrographic surgery with a review of the literature”, J Plast Reconstr Aesthet Surg, 2014, doi: 10.1016/j.bjps.2014.05.021.

  47. Gattoni, M., Tiberio, R., Angeli, L. et al., “Dermatofibrosarcoma protuberans: surgical treatment using the Teubingen technique (31 cases)”, Ann Dermatol Venereol, 2007, 134 (1): 31-34.

  48. Hancox, J.G., Kelley, B. y Greenway, H.T. Jr., “Treatment of dermatofibroma sarcoma protuberans using modified Mohs micrographic surgery: no recurrences and smaller defects”, Dermatol Surg, 2008, 34 (6): 780-784.

  49. McArthur, G.A., Demetri, G.D., Van Oosterom, A. et al., “Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225”, J Clin Oncol, 2005; 23: 866-873.

  50. Rutkowski, P., Przybyl, J. y Switaj, T., “Genetics of rare mesenchymal tumors: Implications for targeted treatment in dfsp, asps, ccs, gctb and pecoma”, Int J Biochem Cell Biol, 2014, doi: 10.1016/j.biocel.2014.03.024.

  51. Maki, R.G., Awan, R.A., Dixon, R.H. et al., “Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans”, Int J Cancer, 2002, 100: 623-626.

  52. Rubin, B.P., Schuetze, S.M., Eary, J.F. et al., “Molecular targeting of platelet derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans”, J Clin Oncol, 2002, 20: 3586-3591.

  53. Mizutani, K., Tamada, Y., Hara, K. et al., “Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans”, Br J Dermatol, 2004, 151: 235-237.

  54. Price, V.E., Fletcher, J.A., Zielenska, M. et al., “Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberans”, Pediatr Blood Cancer, 2005, 44: 1-5.

  55. Mehrany, K., Swanson, N., Heinrich, M.C. et al., “Dermatofibrosarcoma protuberans: a partial response to imatinib therapy”, Dermatol Surg, 2006, 32: 456-459.

  56. Savoia, P., Ortoncelli, M., Quaglino, P. et al., “Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study”, Dermatol Surg, 2006, 32: 1097-1102.

  57. Wright, T. y Petersen, J.E., “Treatment of recurrent dermatofibrosarcoma protuberans with imatinib mesylate, followed by Mohs micrographic surgery”, Dermatol Surg, 2007; 33: 741-744.

  58. Lemm, D., Muegge, L., Hoeffken, K. et al., “Remission with imatinib mesylate treatment in a patient with initially unresectable dermatofibrosarcoma protuberans. A case report”, Oral Maxillofac Surg, 2008, 12: 209-213.

  59. Kamar, F.G., Kairouz, V.F. y Sabri, A.N., “Dermatofibrosarcoma protuberans (dfsp) successfully treated with sorafenib: case report”, Clinical Sarcoma Research, 2013, 3: 1-5.

  60. Sun, L.M., Wang, C.J., Huang, C.C. et al., “Dermatofibrosarcoma protuberans: treatment results of 35 cases”, Radiother Oncol, 2000; 57: 175-181.

  61. Dagan, R., Morris, C.G., Zlotecki, R.A. et al., “Radiotherapy in the treatment of dermatofibrosarcoma protuberans”, Am J Clin Oncol, 2005, 28: 537-539.

  62. Castle, K.O., Guadagnolo, B.A., Tsai, C.J. et al., “Dermatofibrosarcoma protuberans: long term outcomes of 53 patients treated with conservative surgery and radiation therapy”, Int J Radiation Oncol Biol Phys, 2013, 86 (3): 585-590.

  63. Radaelli, S., Stachiotti, S., Casali, P.G. et al., “Emerging therapies for adult soft tissue sarcoma”, Expert Rev Anticancer Ther, 2014, 14 (6): 689-704.

  64. Haas, R.L., Keus, R.B., Loftus, B.M. et al., “The role of radiotherapy in the local management of dermatofibrosarcoma protuberans. Soft tissue Tumours Working Group”, Eur J Cancer, 1997, 33: 1055-1060.

  65. Ballo, M.T., Zagars, G.K., Pisters, P. et al., “The role of radiation therapy in the management of dermatofibrosarcoma protuberans”, Int J Radiat Oncol Biol Phys, 1998, 40: 823-827.

  66. Rutgers, E.J., Kroon, B.B., Albus-Lutter, C.E. et al., “Dermatofibrosarcoma protuberans: treatment and prognosis”, Eur J Surg Oncol, 1992, 18: 241-248.

  67. Liang, A.C., Jambusaria-Pahlajani, A., Karia, P.S. et al., “A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change”, J Am Acad Dermatol, 2014, doi: 10.1016/j.jaad.2014.03.018.

  68. Erderm, O., Wyatt, A.J., Lin, E. et al., “Dermatofibrosarcoma protuberans treated with wide local excision and followed at a cancer hospital: prognostic significance of clinicopathologic variables”, Am J Dermatopsthol, 2012, 34 (1): 24-34.

  69. Kim, M., Huh, C.H., Cho, K.H. et al., “A study on the prognostic value of clinical and surgical features of dermatofibrosarcoma protuberans in Korean patients”, J Eur Acad Dermatol Venereol, 2012, 26 (8): 964-971.




2020     |     www.medigraphic.com